| Mr Bowen J Landry, CRNA | |
|
611 Saint Landry St, Lafayette, LA 70506-4627 | |
| (337) 289-2966 | |
| (337) 289-2776 |
| Full Name | Mr Bowen J Landry |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 27 Years |
| Location | 611 Saint Landry St, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033221668 | NPI | - | NPPES |
| 1472085 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 04487 (Louisiana) | Primary |
| Entity Name | Digestive & Liver Center, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851385827 PECOS PAC ID: 1355307299 Enrollment ID: O20041202000851 |
News Archive
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that its Phase 2 safety study of CUBICIN (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives. This study was a first-of-its-kind randomized controlled Phase 2 trial studying anti-infective therapy in the setting of 2-stage surgery for the replacement of infected prosthetic hip or knee joints.
The odds triple for premature child delivery pregnant women with a history of depression who used psychiatric medication, according to a new study.
The finding has substantial clinical significance, as mutations in these cell survival-signaling pathways are associated with many human cancers, and a better understanding of how these pathways converge to regulate the delicate balance between cell proliferation and cell death may lead to development of more effective cancer therapies.
WHO leaders and international health ministers met Thursday for a two-day meeting in Cancun, Mexico, to share the lessons learned from the spread of H1N1 (swine flu) (Xinhua, 7/3) and strategies for "battling the pandemic," the AP/Washington Post reports (Rodriguez, 7/2).
› Verified 5 days ago
| Entity Name | Texans Anesthesia Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275733982 PECOS PAC ID: 8820171390 Enrollment ID: O20080207000456 |
News Archive
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that its Phase 2 safety study of CUBICIN (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives. This study was a first-of-its-kind randomized controlled Phase 2 trial studying anti-infective therapy in the setting of 2-stage surgery for the replacement of infected prosthetic hip or knee joints.
The odds triple for premature child delivery pregnant women with a history of depression who used psychiatric medication, according to a new study.
The finding has substantial clinical significance, as mutations in these cell survival-signaling pathways are associated with many human cancers, and a better understanding of how these pathways converge to regulate the delicate balance between cell proliferation and cell death may lead to development of more effective cancer therapies.
WHO leaders and international health ministers met Thursday for a two-day meeting in Cancun, Mexico, to share the lessons learned from the spread of H1N1 (swine flu) (Xinhua, 7/3) and strategies for "battling the pandemic," the AP/Washington Post reports (Rodriguez, 7/2).
› Verified 5 days ago
| Entity Name | Bahec Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497079701 PECOS PAC ID: 2668503368 Enrollment ID: O20100624000341 |
News Archive
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that its Phase 2 safety study of CUBICIN (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives. This study was a first-of-its-kind randomized controlled Phase 2 trial studying anti-infective therapy in the setting of 2-stage surgery for the replacement of infected prosthetic hip or knee joints.
The odds triple for premature child delivery pregnant women with a history of depression who used psychiatric medication, according to a new study.
The finding has substantial clinical significance, as mutations in these cell survival-signaling pathways are associated with many human cancers, and a better understanding of how these pathways converge to regulate the delicate balance between cell proliferation and cell death may lead to development of more effective cancer therapies.
WHO leaders and international health ministers met Thursday for a two-day meeting in Cancun, Mexico, to share the lessons learned from the spread of H1N1 (swine flu) (Xinhua, 7/3) and strategies for "battling the pandemic," the AP/Washington Post reports (Rodriguez, 7/2).
› Verified 5 days ago
| Entity Name | Endo Sedation Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588931174 PECOS PAC ID: 4789845363 Enrollment ID: O20120406000221 |
News Archive
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that its Phase 2 safety study of CUBICIN (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives. This study was a first-of-its-kind randomized controlled Phase 2 trial studying anti-infective therapy in the setting of 2-stage surgery for the replacement of infected prosthetic hip or knee joints.
The odds triple for premature child delivery pregnant women with a history of depression who used psychiatric medication, according to a new study.
The finding has substantial clinical significance, as mutations in these cell survival-signaling pathways are associated with many human cancers, and a better understanding of how these pathways converge to regulate the delicate balance between cell proliferation and cell death may lead to development of more effective cancer therapies.
WHO leaders and international health ministers met Thursday for a two-day meeting in Cancun, Mexico, to share the lessons learned from the spread of H1N1 (swine flu) (Xinhua, 7/3) and strategies for "battling the pandemic," the AP/Washington Post reports (Rodriguez, 7/2).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Bowen J Landry, CRNA Po Box 53864, Lafayette, LA 70505-3864 Ph: (337) 289-2966 | Mr Bowen J Landry, CRNA 611 Saint Landry St, Lafayette, LA 70506-4627 Ph: (337) 289-2966 |
News Archive
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that its Phase 2 safety study of CUBICIN (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives. This study was a first-of-its-kind randomized controlled Phase 2 trial studying anti-infective therapy in the setting of 2-stage surgery for the replacement of infected prosthetic hip or knee joints.
The odds triple for premature child delivery pregnant women with a history of depression who used psychiatric medication, according to a new study.
The finding has substantial clinical significance, as mutations in these cell survival-signaling pathways are associated with many human cancers, and a better understanding of how these pathways converge to regulate the delicate balance between cell proliferation and cell death may lead to development of more effective cancer therapies.
WHO leaders and international health ministers met Thursday for a two-day meeting in Cancun, Mexico, to share the lessons learned from the spread of H1N1 (swine flu) (Xinhua, 7/3) and strategies for "battling the pandemic," the AP/Washington Post reports (Rodriguez, 7/2).
› Verified 5 days ago
Charles L. Papadakes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 304, Lafayette, LA 70508 Phone: 337-988-5646 Fax: 337-988-4298 | |
Mr. Stephen Kyle Chauvin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 314 Youngsville Hwy, Lafayette, LA 70508 Phone: 337-706-1500 | |
Brittany Dibetta Belk, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 215 Republic Ave, Apt 6105, Lafayette, LA 70508 Phone: 504-451-4464 | |
Paula L. Simon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4200 W Congress St, Suite 3200, Lafayette, LA 70506 Phone: 337-981-3546 | |
Dexter Paul Guidry Ii, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4212 W Congress St, Suite 3200, Lafayette, LA 70506 Phone: 337-981-3546 Fax: 337-988-4298 | |
Mr. Jude L Guillory, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 304, Lafayette, LA 70508 Phone: 337-988-5646 Fax: 337-988-4298 |